Blackbaud
BLKB
44.52
+1.01
+2.32%
Blackbaud
US · BLKB
#2814 by market cap
Listed 1970
44.52
+1.01
+2.32%
Live - 5344 symbols - heartbeat 473s ago
· 2026-10-07 19:54
After-hours
44.52
0.00%
- Market cap
- 2.02B
- P/E (TTM)i
- 13.91
- P/Bi
- 30.14
- EPSi
- 2.37
- Div yieldi
- 0.00%
- 52W posi
- 42%
Reader sentiment
Are you bullish or bearish on BLKB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.14, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.27% YoY
Margins
- Gross margin
- 58.78%
- Operating margin
- 16.91%
- Net margin
- 10.19%
Key ratios & quality
- Enterprise valuei
- 3.09B
- Altman Z-Scorei
- 1.14
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 848.61M | 900.42M | 913.22M | 927.74M | 1.06B | 1.11B | 1.15B | 1.13B |
| Gross profit | 466.86M | 482.00M | 485.15M | 484.55M | 552.72M | 599.06M | 631.43M | 663.29M |
| Selling & admin expenses | 299.20M | 337.57M | 344.61M | 332.58M | 421.36M | 402.10M | 340.22M | 332.17M |
| Research & development | 98.81M | 106.16M | 100.15M | 124.57M | 156.91M | 147.47M | 153.68M | 138.13M |
| Operating profit | 64.01M | 32.95M | 37.48M | 25.17M | -28.49M | 46.35M | 133.98M | 190.75M |
| Pretax profit | 44.62M | 10.59M | 21.61M | 7.08M | -55.58M | 19.29M | -312.46M | 131.78M |
| Tax | -219.00K | -1.32M | 13.90M | 1.39M | -10.17M | 16.27M | -12.94M | 16.81M |
| Net profit | 44.84M | 11.91M | 7.72M | 5.70M | -45.41M | 3.02M | -299.52M | 114.97M |
| Basic EPS | 1 | 0 | 0 | 0 | -1 | 0 | -6 | 2 |
| Diluted EPS | 0.93 | 0.25 | 0.16 | 0.12 | -0.88 | 0.06 | -5.92 | 2.37 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 269.94M | 282.03M | 281.14M | 295.26M | 281.14M | 290.60M |
| Gross profit | 155.12M | 168.40M | 167.49M | 172.28M | 166.56M | 178.16M |
| Selling & admin expenses | 101.32M | 76.90M | 75.15M | 78.80M | 77.61M | 80.71M |
| Research & development | 33.56M | 33.60M | 37.20M | 33.78M | 36.92M | 34.86M |
| Operating profit | 19.71M | 57.33M | 54.57M | 59.14M | 51.45M | 62.02M |
| Pretax profit | 4.87M | 40.04M | 41.04M | 45.83M | 37.81M | 46.42M |
| Tax | 542.00K | 13.58M | -6.45M | 9.14M | 6.67M | 11.06M |
| Net profit | 4.32M | 26.47M | 47.49M | 36.69M | 31.14M | 35.36M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.09 | 0.55 | 0.98 | 0.76 | 0.67 | 0.79 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 597.98M | 734.54M | 819.06M | 850.97M | 918.64M | 929.76M | 976.59M | 930.09M |
| Cash & ST investments | 30.87M | 31.81M | 35.75M | 55.15M | 31.69M | 31.25M | 67.63M | 38.91M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.62B | 1.99B | 2.04B | 2.97B | 2.99B | 2.91B | 2.50B | 2.39B |
| Total current liabilities | 805.66M | 988.84M | 1.01B | 1.11B | 1.23B | 1.20B | 1.25B | 1.18B |
| Short-term debt | 7.50M | 7.50M | 12.84M | 18.70M | 18.80M | 19.26M | 28.36M | 24.22M |
| Long-term debt | 379.62M | 459.60M | 518.19M | 937.48M | 840.24M | 760.41M | 1.05B | 1.09B |
| Total liabilities | 1,241,522,000.00 | 1,596,199,000.00 | 1,618,584,000.00 | 2,254,557,000.00 | 2,248,671,000.00 | 2,103,574,000.00 | 2,369,161,000.00 | 2,305,628,000.00 |
| Total equity | 373.78M | 396.76M | 426.15M | 717.06M | 744.03M | 808.71M | 126.84M | 85.05M |
| Retained earnings | 246.48M | 234.86M | 236.71M | 242.46M | 197.05M | 198.87M | -99.46M | 15.51M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 627.45M | 1.15B | 638.84M | 930.09M | 642.22M | 1.12B |
| Cash & ST investments | 37.24M | 41.57M | 38.26M | 38.91M | 34.10M | 34.39M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.10B | 2.63B | 2.10B | 2.39B | 2.11B | 2.59B |
| Total current liabilities | 863.90M | 1.38B | 929.38M | 1.18B | 866.68M | 1.35B |
| Short-term debt | 23.35M | 24.01M | 24.20M | 24.22M | 23.16M | 22.60M |
| Long-term debt | 1.18B | 1.14B | 1.04B | 1.09B | 1.16B | 1.13B |
| Total liabilities | 2,069,044,000.00 | 2,541,443,000.00 | 1,996,252,000.00 | 2,305,628,000.00 | 2,074,744,000.00 | 2,527,466,000.00 |
| Total equity | 33.18M | 87.95M | 108.19M | 85.05M | 34.55M | 67.03M |
| Retained earnings | -79.44M | -53.46M | -21.18M | 15.51M | 46.65M | 82.01M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 201.39M | 182.48M | 147.96M | 213.66M | 203.89M | 199.63M | 295.97M | 265.55M |
| Depreciation & amortization | 79.57M | 85.69M | 92.74M | 82.41M | 102.37M | 109.49M | 121.67M | 86.22M |
| Free cash flow | 149.04M | 124.11M | 76.11M | 161.51M | 132.83M | 135.51M | 228.77M | 203.55M |
| Dividends paid | -23.31M | -23.61M | -5.96M | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -41.00M | -108.42M | 0 | -18.83M | -418.03M | -217.15M |
| Ending cash balance | 449.85M | 577.30M | 644.97M | 651.76M | 733.93M | 728.26M | 809.51M | 758.98M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.39M | 66.94M | 139.21M | 58.01M | 51.46M | 91.05M |
| Depreciation & amortization | 21.65M | 21.70M | 21.31M | 21.56M | 20.55M | 20.74M |
| Free cash flow | -12.27M | 51.50M | 123.24M | 41.08M | 36.99M | 75.28M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -100.03M | -3.18M | -30.13M | -83.81M | -82.10M | -29.53M |
| Ending cash balance | 456.64M | 911.81M | 457.44M | 758.98M | 452.77M | 881.01M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.18 | 3.09 | 1.88 | 1.00 | -6.22 | 0.23 | -59.57 | 101.27 |
| ROA %i | 2.66 | 0.66 | 0.38 | 0.23 | -1.52 | 0.06 | -10.47 | 4.71 |
| ROIC %i | 7.30 | 2.90 | 1.98 | 1.47 | -1.04 | 1.61 | -16.78 | 13.65 |
| 5-year avg ROE %i | 17.38 | 14.74 | 12.53 | 8.76 | 2.48 | 0.03 | -13.40 | 7.93 |
| EBIT margin %i | 7.13 | 3.47 | 4.26 | 2.70 | -1.87 | 5.21 | -22.15 | 17.70 |
| FCF / sales %i | 17.56 | 13.78 | 8.33 | 17.41 | 12.55 | 12.26 | 19.80 | 18.04 |
| Current ratioi | 0.74 | 0.74 | 0.81 | 0.77 | 0.75 | 0.78 | 0.78 | 0.79 |
| Quick ratioi | 0.15 | 0.12 | 0.13 | 0.14 | 0.11 | 0.11 | 0.12 | 0.10 |
| Debt / assetsi | 23.97 | 28.24 | 26.82 | 33.97 | 30.21 | 28.15 | 44.62 | 46.68 |
| LT debt / equityi | 101.56 | 139.94 | 125.67 | 138.18 | 118.97 | 98.98 | 855.65 | 1,283.47 |
| Interest coveragei | 3.81 | 1.51 | 2.25 | 1.39 | -0.55 | 1.44 | -4.60 | 2.94 |
| Revenue CAGR (3Y) %i | 9.98 | 7.16 | 5.02 | 3.02 | 5.53 | 6.63 | 7.57 | 2.17 |
| Net income CAGR (3Y) %i | 20.47 | -35.99 | -52.85 | -49.73 | -- | -26.87 | -- | -- |
| FCF CAGR (3Y) %i | 16.15 | 4.24 | -17.94 | 2.71 | 2.29 | 21.20 | 12.31 | 15.29 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -99.98 | -83.99 | -77.16 | 101.27 | 418.69 | 194.45 |
| ROA %i | -12.19 | -9.85 | -10.70 | 4.71 | 6.73 | 5.77 |
| ROIC %i | -16.44 | -15.68 | -14.50 | 13.65 | 15.65 | 16.36 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -21.58 | -20.60 | -19.67 | 17.70 | 20.34 | 20.67 |
| FCF / sales %i | 14.40 | 16.13 | 19.27 | 18.04 | 22.18 | 24.09 |
| Current ratioi | 0.73 | 0.84 | 0.69 | 0.79 | 0.74 | 0.83 |
| Quick ratioi | 0.14 | 0.14 | 0.13 | 0.10 | 0.14 | 0.13 |
| Debt / assetsi | 57.47 | 44.33 | 50.90 | 46.68 | 56.24 | 44.32 |
| LT debt / equityi | 3,571.18 | 1,298.05 | 967.78 | 1,283.47 | 3,366.27 | 1,681.95 |
| Interest coveragei | -3.97 | -3.62 | -3.30 | 2.94 | 3.46 | 3.58 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.